Transplant Infectious Disease最新文献

筛选
英文 中文
Research Advice for Early Career Transplant Infectious Disease Clinicians. 早期职业移植传染病临床医生的研究建议。
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-29 DOI: 10.1111/tid.70041
Rebecca N Kumar, Michael J Scolarici, Chelsea Gorsline, Lara Danziger-Isakov, John Baddley, Courtney E Harris
{"title":"Research Advice for Early Career Transplant Infectious Disease Clinicians.","authors":"Rebecca N Kumar, Michael J Scolarici, Chelsea Gorsline, Lara Danziger-Isakov, John Baddley, Courtney E Harris","doi":"10.1111/tid.70041","DOIUrl":"https://doi.org/10.1111/tid.70041","url":null,"abstract":"<p><p>As part of an ongoing series of social media discussions, the Transplant Infectious Diseases Early Career Network hosted an open forum for the transplant infectious disease community to discuss the development of research careers for junior faculty. Topics discussed included opportunities for research, identifying potential research questions, institutional support, grant funding, common barriers to research, and trainee involvement. The forum highlighted symbiotic relationships between junior faculty and trainees. The insights from the forum provide a valuable resource for early-career transplant infectious diseases (TID) researchers.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70041"},"PeriodicalIF":2.6,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Combination Therapy with Cefiderocol and Sulbactam-Durlobactam for Donor-Derived Carbapenem-Resistant Acinetobacter baumannii in a Kidney Transplant Recipient. 头孢地罗和舒巴坦-杜氯巴坦联合治疗肾移植受者供体来源的耐碳青霉烯鲍曼不动杆菌的成功。
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-29 DOI: 10.1111/tid.70048
Allyssa R Webb, Anmary Fernandez, Nicholas Piccicacco
{"title":"Successful Combination Therapy with Cefiderocol and Sulbactam-Durlobactam for Donor-Derived Carbapenem-Resistant Acinetobacter baumannii in a Kidney Transplant Recipient.","authors":"Allyssa R Webb, Anmary Fernandez, Nicholas Piccicacco","doi":"10.1111/tid.70048","DOIUrl":"https://doi.org/10.1111/tid.70048","url":null,"abstract":"","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70048"},"PeriodicalIF":2.6,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143996946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation. 巴西接受同种异体造血干细胞移植患者中共生病毒的分子特征和动力学。
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-29 DOI: 10.1111/tid.70037
Gabriel Montenegro de Campos, Thalita Cristina de Mello Costa, Anielly Sarana da Silva, Lara Okuyama Afonso Costa, Roberta Maraninchi Silveira, Ian Nunes Valença, Felipe Santos de Carvalho, Luiz Guilherme Darrigo Júnior, Rodrigo Haddad, Ana Carolina de Jesus Vieira, Camila Campos Mesquita, Patrícia da Silva Laurindo, Renato Guerino Cunha, Luiz Carlos Júnior Alcântara, Simone Kashima, Dimas Tadeu Covas, Belinda Pinto Simões, Sandra Coccuzzo Sampaio, Maria Carolina Elias, Marta Giovanetti, Dennis Maletich Junqueira, Svetoslav Nanev Slavov
{"title":"Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.","authors":"Gabriel Montenegro de Campos, Thalita Cristina de Mello Costa, Anielly Sarana da Silva, Lara Okuyama Afonso Costa, Roberta Maraninchi Silveira, Ian Nunes Valença, Felipe Santos de Carvalho, Luiz Guilherme Darrigo Júnior, Rodrigo Haddad, Ana Carolina de Jesus Vieira, Camila Campos Mesquita, Patrícia da Silva Laurindo, Renato Guerino Cunha, Luiz Carlos Júnior Alcântara, Simone Kashima, Dimas Tadeu Covas, Belinda Pinto Simões, Sandra Coccuzzo Sampaio, Maria Carolina Elias, Marta Giovanetti, Dennis Maletich Junqueira, Svetoslav Nanev Slavov","doi":"10.1111/tid.70037","DOIUrl":"https://doi.org/10.1111/tid.70037","url":null,"abstract":"<p><strong>Background: </strong>Commensal viruses are typically well-tolerated by healthy individuals, but their behavior in immunocompromised patients is not fully understood.</p><p><strong>Methods: </strong>This study investigated the prevalence, molecular dynamics, and circulating genotypes of human pegivirus-1 (HPgV-1) and three types of torque teno viruses (TTV-3, -16, and -22) in Brazilian patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Plasma samples from 20 patients were collected at three time points: pretransplantation (D+0), 30 days post-transplantation (D+30), and 100 days post-transplantation (D+100). We conducted longitudinal screening for HPgV-1 and three TTV variants using real-time PCR, comparing cycle threshold values across these intervals.</p><p><strong>Results: </strong>The overall HPgV-1 RNA prevalence at all collection points was 45% (n = 9/20), with all infected individuals carrying genotype 2. HPgV-1 infections exhibited stable, closely related strains over time, though virus evolution was highly individualized. The overall prevalence of TTV types was 5% for TTV-3, 30% for TTV-16, and 60% for TTV-22. Notably, all commensal viruses showed a decrease in cycle threshold at D+100, indicating a possible increase in viral load.</p><p><strong>Conclusion: </strong>These findings underscore the importance of commensal viruses in the context of HSCT and suggest their potential role as biomarkers for immune suppression and transplantation outcomes. Further research is warranted to elucidate their implications.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70037"},"PeriodicalIF":2.6,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143983822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the Challenge of Bacterial Infections and Antimicrobial Stewardship in Heart Transplant Recipients: Beating in Harmony. 应对心脏移植受者细菌感染和抗菌药物管理的挑战:和谐的跳动。
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-29 DOI: 10.1111/tid.70034
Miranda So
{"title":"Addressing the Challenge of Bacterial Infections and Antimicrobial Stewardship in Heart Transplant Recipients: Beating in Harmony.","authors":"Miranda So","doi":"10.1111/tid.70034","DOIUrl":"https://doi.org/10.1111/tid.70034","url":null,"abstract":"","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70034"},"PeriodicalIF":2.6,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143983820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge and Adherence to Lifestyle Habits to Prevent Complications Associated With Immunosuppression in Kidney Transplant Recipients: A Single-Center Survey. 了解和坚持生活习惯预防肾移植受者免疫抑制相关并发症:一项单中心调查
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-26 DOI: 10.1111/tid.70038
Tamara Ruiz-Merlo, Isabel Rodríguez-Goncer, Francisco López-Medrano, Natalia Polanco, Esther González, Hernando Trujillo, Marina Fayos, Natalia Redondo, Rafael San Juan, Amado Andrés, José María Aguado, Mario Fernández-Ruiz
{"title":"Knowledge and Adherence to Lifestyle Habits to Prevent Complications Associated With Immunosuppression in Kidney Transplant Recipients: A Single-Center Survey.","authors":"Tamara Ruiz-Merlo, Isabel Rodríguez-Goncer, Francisco López-Medrano, Natalia Polanco, Esther González, Hernando Trujillo, Marina Fayos, Natalia Redondo, Rafael San Juan, Amado Andrés, José María Aguado, Mario Fernández-Ruiz","doi":"10.1111/tid.70038","DOIUrl":"https://doi.org/10.1111/tid.70038","url":null,"abstract":"<p><strong>Background: </strong>Chronic immunosuppression associated with certain lifestyle habits render kidney transplant (KT) recipients more susceptible to infection and cancer. We assessed the level of knowledge and adherence to safe living strategies to minimize the occurrence of posttransplant complications.</p><p><strong>Methods: </strong>Consecutive KT recipients were offered a self-administered questionnaire covering the following areas: demographics and socioeconomic factors; generic hygiene habits; sun exposure; smoking and alcohol consumption; vaccination status; animal contact and gardening; international travelling; and food safety and habits.</p><p><strong>Results: </strong>Between May 2019 and May 2021, 130 KT recipients responded the survey at a median of 61.5 posttransplant days (completion rate of 94.9%). Only 19.7% of participants visited the dentist at least every 3-6 months. Although the majority (88.5%) were aware of the need of sunscreen, only 23.3% used it throughout the year. Self-reported influenza vaccine uptake in the last session was 69.1%. Pet ownership was reported by 41.7% of participants, of which more than one-third had considered to give up the care of their animals. Gardening and international travel were uncommon. A notable proportion of participants acknowledged to consume the following products either \"usually\" or \"often\": raw or undercooked meat (12.4%), undercooked fish (24.8%), raw seafood (8.8%), homemade sausages or cured ham (51.5%), pâté or meat spreads (35.2%), and \"ready-to-eat\" salads (31.8%). Adherence was poorer among non-native-speaking patients and those with lower education and household incomes.</p><p><strong>Conclusion: </strong>There is room for improvement in health education and promotion practices among KT recipients, particularly those with potential cultural and socioeconomic barriers.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70038"},"PeriodicalIF":2.6,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-of-Care Testing by Multiplex-PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation-Results of a Prospective Study. 肺移植后疑似下呼吸道感染的不同房室多重pcr即时检测——一项前瞻性研究的结果
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-26 DOI: 10.1111/tid.70036
Susanne Simon, Merle Sophie Kaiser, Marcus Bachmann, Gérard Krause, Jens Gottlieb
{"title":"Point-of-Care Testing by Multiplex-PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation-Results of a Prospective Study.","authors":"Susanne Simon, Merle Sophie Kaiser, Marcus Bachmann, Gérard Krause, Jens Gottlieb","doi":"10.1111/tid.70036","DOIUrl":"https://doi.org/10.1111/tid.70036","url":null,"abstract":"<p><strong>Background: </strong>Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx). This study evaluated a point-of-care multiplex-PCR testing system (POCTmPCR) for pathogen detection in various respiratory samples from LTx recipients.</p><p><strong>Methods: </strong>In a prospective single-center study, LTx recipients with RTI undergoing bronchoscopy were enrolled. Samples from bronchoalveolar lavage (BAL), sputum, and nasopharyngeal swabs (NPS) were analyzed by POCTmPCR in conjunction with conventional diagnostics. The primary study endpoint was the concordance of POCTmPCR results between samples (DRKS00032359).</p><p><strong>Results: </strong>Fifty participants with a median age of 48 years were included; 28 (56%) were previously colonized. Using POCTmPCR, 44 bacterial pathogens were identified in BAL from 30 patients, 49 in sputum (30 patients), and 33 in NPS (17 patients). POCTmPCR identified 24 viral pathogens in BAL from 20 patients, 22 pathogens in sputum of 19 patients, and 19 in NPS of 19 patients. For viral POCTmPCR, sensitivity and specificity compared to BAL were 84% and 97% in sputum, and 80% and 97% in NPS, respectively. For bacterial POCTmPCR, sensitivity and specificity were 80% and 67% in sputum, and 37% and 85% in NPS, respectively. POCTmPCR in comparison to conventional workup had a sensitivity of 89% and 80% and specificity of 75% and 76% for viral and bacterial pathogens, respectively.</p><p><strong>Conclusion: </strong>POCTmPCR in nasal swabs and sputum may serve as an alternative to BAL for detecting respiratory viruses. Performance for bacterial detection in noninvasive samples was lower. The POCTmPCR system used lacks detection for SARS-CoV-2 and Aspergillus spp.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70036"},"PeriodicalIF":2.6,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144035882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma. 复发/难治性多发性骨髓瘤患者在Idecabtagene微球治疗期间巨细胞病毒视网膜炎。
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-21 DOI: 10.1111/tid.70040
Taku Kikuchi, Miyu Watanabe, Nobuhiro Tsukada, Chiaki Matsumoto, Moe Nomura-Yogo, Kodai Kunisada, Haruka Sawada, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Osamu Hosoya, Tadao Ishida
{"title":"Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma.","authors":"Taku Kikuchi, Miyu Watanabe, Nobuhiro Tsukada, Chiaki Matsumoto, Moe Nomura-Yogo, Kodai Kunisada, Haruka Sawada, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Osamu Hosoya, Tadao Ishida","doi":"10.1111/tid.70040","DOIUrl":"https://doi.org/10.1111/tid.70040","url":null,"abstract":"<p><strong>Background: </strong>Chimeric antigen receptor T-cell (CAR-T) therapy has improved outcomes in patients with triple-class-exposed relapsed/refractory multiple myeloma (RRMM); however, it is associated with complications, including infections. Cytomegalovirus (CMV) infection is one of the infections associated with idecabtagene vicleucel (ide-cel) treatment. While there have been several reports on CMV replication, CMV retinitis has only been documented in case reports, making it a severe but under-reported complication.</p><p><strong>Study design: </strong>This retrospective single-institution study was conducted at the Japanese Red Cross Medical Center. The study analyzed the clinical features of CMV retinitis in 53 patients with RRMM treated with ide-cel between December 2022 and December 2024. CMV retinitis was diagnosed based on ophthalmological findings, with CMV polymerase chain reaction (PCR) confirmation in the vitreous fluid, if necessary.</p><p><strong>Results: </strong>The cumulative incidence of CMV retinitis at 6 months was 9.2%, with a median onset time of 2.2 months postinfusion. Among the four patients with CMV retinitis, three patients experienced visual impairment and one patient was asymptomatic. One patient was diagnosed with CMV retinitis, despite having negative serum CMV PCR results, which highlights the limitations of replication-based screening. All patients required treatment, with one patient achieving improvement and three patients undergoing ongoing treatments.</p><p><strong>Conclusions: </strong>CMV retinitis is a significant complication of ide-cel therapy. Regular CMV PCR is important, but early ophthalmological consultations are crucial for timely detection and management, even in the absence of CMV replication, particularly when visual impairment develops. Further studies are needed to identify the risk factors and establish preventive strategies.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70040"},"PeriodicalIF":2.6,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant. 儿童实体器官移植1年内受者的菌血症。
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-21 DOI: 10.1111/tid.70030
Mario M Landa, Ayelet Rosenthal, Caitlin Naureckas Li, Mehreen Arshad, Sameer Patel, Larry Kociolek, Alyah Barnes, Stella Karuri, William J Muller
{"title":"Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant.","authors":"Mario M Landa, Ayelet Rosenthal, Caitlin Naureckas Li, Mehreen Arshad, Sameer Patel, Larry Kociolek, Alyah Barnes, Stella Karuri, William J Muller","doi":"10.1111/tid.70030","DOIUrl":"https://doi.org/10.1111/tid.70030","url":null,"abstract":"<p><strong>Background: </strong>Bacteremia is a major cause of morbidity and mortality in immunocompromised children, yet there are limited data in children who have undergone solid organ transplantation (SOT).</p><p><strong>Methods: </strong>We retrospectively reviewed bloodstream infections (BSI) in 581 recipients of heart, liver, or kidney transplants over a 14-year period.</p><p><strong>Results: </strong>Overall 1-year incidence in this population was 8.4%, and was highest in recipients of liver transplants compared to heart or kidney. Younger age, transplantation earlier in the time period studied, need for repeat surgery within 30 days of transplant, and prior diagnosis of diabetes or tumor were associated with an increased risk of BSI. Most BSI occurred within 90 days of transplant, and most were associated with central venous lines. Coagulase-negative staphylococci and enteric commensals were commonly isolated. Multiple BSI within the year after transplant were uncommon. Although overall mortality was not increased in patients with BSI compared to those without, patients with BSI had more total hospitalizations and more days spent in the hospital in the year following SOT.</p><p><strong>Conclusion: </strong>In a large pediatric SOT population, overall BSI rates were significant but decreased over time. Identifying factors which contribute to BSI after SOT may direct interventions that can impact inpatient care requirements for these patients.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70030"},"PeriodicalIF":2.6,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144020383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis. 同种异体干细胞移植儿童接受莱特莫韦预防巨细胞病毒的临床意义
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-20 DOI: 10.1111/tid.70032
Christina Oikonomopoulou, Anna Paisiou, Aikaterini Kaisari, Eleni-Dikaia Ioannidou, Anna Komitopoulou, Marina Letsiou, Ioannis Grafakos, Michalis Kastamoulas, Georgia Stavroulaki, Sofia Hante, Evgenios Goussetis
{"title":"Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis.","authors":"Christina Oikonomopoulou, Anna Paisiou, Aikaterini Kaisari, Eleni-Dikaia Ioannidou, Anna Komitopoulou, Marina Letsiou, Ioannis Grafakos, Michalis Kastamoulas, Georgia Stavroulaki, Sofia Hante, Evgenios Goussetis","doi":"10.1111/tid.70032","DOIUrl":"https://doi.org/10.1111/tid.70032","url":null,"abstract":"<p><strong>Background: </strong>Cytomegalovirus (CMV) infection and disease constitute an important complication of allogeneic hematopoietic stem cell transplantation with high morbidity. Letermovir prophylactic use in adult recipients has reduced the incidence of CMV infection with minimal toxicity. Relevant data on children is scarce, and letermovir has been used off-label. Recently, a couple of studies indicated an association of letermovir with EBV reactivation/PTLD in adults, raising a significant concern.</p><p><strong>Methods: </strong>We aimed to retrospectively compare ultra-high-risk for CMV infection children with leukemia [seropositive children/seronegative donors], who received (LET-group) or did not receive (not LET-group) letermovir. Primary objectives were cumulative incidence (CI) of CMV reactivation, EBV reactivation, and clinically significant EBV infection (csEBVi).</p><p><strong>Results: </strong>A total of 37 patients (median age 8.2 years), LET-group-11 and not LET-group-26, were included. The median follow-up was 34.3 months. Compared to the not LET group, patients of the LET group had a lower CI of CMV reactivation, 10% versus 38.4%, p = 0.07, a higher CI of EBV reactivation, 55%, referring to 6/11 patients, versus 23%, p = 0.07, and a higher CI of csEBVI, 40% (4/11 patients) versus 0%, p < 0.001. No patient in the LET group developed GvHD, compared to 23% for aGvHD p = 0.08 and 11.5% for cGvHD p = 0.25 in the non-LET group.</p><p><strong>Conclusion: </strong>Our study confirms letermovir's effectiveness against CMV. Yet, it also reports a high incidence of EBV reactivation and significant EBV infection, as well as a reduced GvHD prevalence in children receiving the drug. Our single-center, retrospective analysis has major limitations but raises a concern. Our findings require further validation in larger, multicenter, prospective studies.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70032"},"PeriodicalIF":2.6,"publicationDate":"2025-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation. 心脏移植术后重症监护期间细菌感染的挑战。
IF 2.6 4区 医学
Transplant Infectious Disease Pub Date : 2025-04-20 DOI: 10.1111/tid.70031
Rita Minucci, Annalisa De Silvestri, Patrizia Cambieri, Marta Corbella, Carlo Pellegrini, Silvia Roda, Chiara Dezza, Stefano Pelenghi, Raffaele Bruno, Mirko Belliato, Elena Seminari
{"title":"The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation.","authors":"Rita Minucci, Annalisa De Silvestri, Patrizia Cambieri, Marta Corbella, Carlo Pellegrini, Silvia Roda, Chiara Dezza, Stefano Pelenghi, Raffaele Bruno, Mirko Belliato, Elena Seminari","doi":"10.1111/tid.70031","DOIUrl":"https://doi.org/10.1111/tid.70031","url":null,"abstract":"<p><strong>Background: </strong>Infections occurring in the early post-heart transplant (HT) period heavily contribute to morbidity and mortality. Our goal is to evaluate the incidence of hospital-acquired pneumonia/ventilator-associated pneumonia (HAP/VAPs) and/or bloodstream infections (BSIs) after HT during the intensive care unit (ICU) stay and identify their associated risk factors in our tertiary hospital.</p><p><strong>Methods: </strong>Observational prospective study including all adult patients who consecutively underwent HT from January 1, 2015 to August 31, 2023 at Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. HAP/VAPs and BSIs diagnosed during ICU were included in the analysis.</p><p><strong>Results: </strong>A total of 106 patients were included, 38 of whom had at least one infectious episode (35.8%), for a total of 57 independent episodes and their incidence was 2.2 per 100 days (95% CI 1.7-2.8). Length of ICU stay was 8 days (IQR: 6-11) for patients without infectious events and 27 days (IQR 14-52) for those with infectious events (p < 0.001). Gram-negative bacteria were associated with 62.8% of BSIs (mainly Enterobacterales) and with 77.9% of HAP/VAP, in this setting Pseudomonas aeruginosa accounted for 17.6% of infections while Klebsiella spp. accounted for 22.1% of infections. Colonization with resistant bacteria (HR 2.21, 95% CI 1.12-4.35) was associated with increased risk of infections while perioperative antimicrobial prophylaxis (PAP) covering Gram-negative bacteria at transplant (HR 0.45, 95% CI 0.23-0.90, p = 0.023) was a protective factor.</p><p><strong>Conclusion: </strong>This study shows that Gram-negative infections represent the major challenge for HT patients during ICU stay and shows some evidence in support of the PAP covering Gram-negative infections at transplant.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70031"},"PeriodicalIF":2.6,"publicationDate":"2025-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144038640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信